hypoxia and no significant change in Pco2 and H+. Two patients were restudied, receiving oxygen therapy overnight. Both had improved sleep but one, who had an intact hypoxic drive to breathing, developed marked hypercapnia and acidosis when his Po2 was restored to normal during sleep; the other, who had no hypoxic drive to breathing, developed no more hypercapnia or acidosis during sleep when breathing oxygen than when breathing air. Oxygen therapy may improve sleep disturbance in these patients, but its effect on the drive to breathing during sleep should be considered ifsevere hypercapnia and acidosis are to be avoided.
Hypoxia, hypercapnia, and acidosis (Mangold et al., 1955; Birchfield, Sieker, and Heyman, 1958; Robin et al., 1958; Sieker, Heyman, and Birchfield, 1960; Billow, 1963; Bristow et al., 1969; Townsend, Prinz, and Obrist, 1973) associated with a reduction in the ventilatory response to inhaled C02 and alveolar ventilation (Birchfield et al., 1958; Reed and Kellogg, 1958; Robin et al., 1958; Bellville et al., 1959; Sieker et al., 1960; Biilow, 1963; Honda and Natsui, 1967) are known to occur during sleep in normal man. These arterial blood gas tensions may be exaggerated in patients with chronic ventilatory failure (Robin, 1958; Koo, Sax, and Snider, 1975) who already have a marked reduction in the ventilatory response to inhaled CO2 (Alexander et al., 1955; Flenley, Franklin, and Millar, 1970) . We have examined the arterial blood gas tensions, H+, and EEG during sleep in patients with severe chronic ventilatory failure and cor pulmonale secondary to chronic airways obstruction.
PATIENTS AND METHODS
Eight male and two female patients, mean age 58 -6 5 8 (SD) years, who were being assessed for longterm oxygen therapy, were studied. None was obese and all had severe airways obstruction (mean FEVi.o 0'57±0-19 1) with hypoxia (mean Pao2 6-8+0-7 kPa), hypercapnia (mean Paco2 7-6±10 kPa), polycythaemia (mean red cell mass 35 +11 ml/kg), and pulmonary hypertension (mean pulmonary artery pressure 4-1 ±0-7 kPa). The steady state ventilatory response to inhaled CO2 was markedly reduced in seven of the eight patients in whom it was measured (mean 5 25±3 0 1 min-' kPa Paco2-'). All were in a stable clinical state at the time of the study. Nine patients routinely took digoxin and diuretics and seven used adrenergic bronchodilators. Two were receiving antibiotics and two a small dose of prednisolone during the study. Three patients had received hypnotics (2 nitrazepam and 1 glutethimide) but none was taken during the period of the study. One patient continued to take meprobamate, 200 mg three times a day, during the study.
As part of the assessment for long-term oxygen therapy, an indwelling arterial catheter had previously been inserted percutaneously by the Seldinger technique in the brachial artery. Hypoxic drive to breathing was assessed in seven of the patients by measuring the fall in Pco2 during 5% CO2 inhalation when the arterial P02 was reduced from hyperoxic 730 (mean Po2 24-8+2-8 (SD) kPa) to hypoxic (mean P02 6 7 ±0 7 kPa) levels. Two patients did not reduce their Pco2 and were considered to have absent or markedly diminished hypoxic drive to breathing using this test. Five patients did reduce their Pco2 in response to the hypoxic stimulus (range of fall in Pco2 0-5-1.3 kPa) and were considered to have a hypoxic drive to breathing.
The patients slept in a single quiet side room on the nights of the studies. At approximately 2200 hours electrodes were placed around the patients' eyes, under the chin, and on the head in the midline so as to record eye movements, muscle tone, and EEG during sleep (Evans et al., 1968) . The electrodes were connected to a lengthy harness, which allowed the patient a very free range of movement, and eventually to a portable eight-channel electroencephalographic machine placed in the corridor outside the room. This ran continuously from approximately 2230 hours until the time that the patient indicated he wanted to stop, which was generally about 0700 hours. At the times of starting and finishing an arterial blood sample, a signal was fed to the machine so that the type of sleep present at sampling could be accurately known. Sleep records were read by standard criteria (Rechtschaffen and Kales, 1968 ) and divided into stages of sleep. The analysis of sleep records consists of identifying successive stages of sleep according to the frequencies present in the EEG and the absence of other physiological changes. Stage 5 or REM sleep is indicated by a drop in muscle tone and the onset of large siccadic eye movements. The record is read as areas of change from one stage of sleep to another continuously throughout the night, and the values (Table II) are obtained by summing the amounts of each stage present over the whole night and measuring the latency of appearance of stage 2 sleep and REM sleep.
Arterial blood samples were taken through a 100 cm catheter connected to the arterial catheter. Control samples were obtained in duplicate with the patient awake and supine after 30 minutes in bed. The room was then darkened and blood samples were obtained thereafter at approximately half-hour intervals throughout the night, two final samples being taken as soon after the patient wakened as possible.
One patient with and one without a hypoxic drive to breathing were restudied overnight when oxygen therapy was being given at a flow rate of 2 litres min-I by nasal catheters. The procedures were approved by the Hospital Ethical Committee, and informed consent was obtained from the patients before each study. (TABLE I) P02 fell significantly (P<0.001) from a mean control value of 6-98±0-21 (SEM) kPa to a mean value during sleep of 6-3 1 ±0-28 kPa. The mean maximal fall in Po2 for the group of subjects was 1 2 kPa (range 0 7-1 9 kPa).
RESULTS

ARTERIAL Po2
Po2 was on average lower after the period of sleep (mean value 6-70+0-28 kPa) but the difference was not significant. A fall in Po2 was usually seen within the first hour of sleep, but there was no consistent relationship between Po2, sleep stage or time after onset of sleep. ARTERIAL PCo2 (TABLE I; FIG. 1) The mean PCO2 was 7-71±0-32 kPa in the control period and 7-94+0-28 Po2 values Control 7-6 7-6 7-5 7-5 7-3 7-3 6-5 6-5 6-3 5.7 6-98 0-21 11-5 10-3 Lowest sleep 6-5 6-9 5-6 (0) andpatient 9 (a) when breathing oxygen (2 litres/min) and air. The mean sleep Po2 was 7 0 and 5 2 kPa on air and 11 0 and 11*5 kPa on oxygen for patients 6 and 9 respectively. kPa during sleep, the difference not being significant. The mean rise in Pco2 during sleep was not related to the ventilatory response to inhaled CO2, and there was no consistent relationship between Pco2, sleep stage or time after onset of sleep. There was a significant (P < 0-02) positive correlation on linear regression between mean sleep Po2 and the mean rise in Pco2 during sleep for each subject who had a demonstrable hypoxic drive. ARTERIAL H+ (TABLE I) The mean control value of 40-9+1 5 nmol 1-1 and the mean sleep value of 41 6 + 11 nmol 1in the eight subjects studied did not ARTERIAL BLOOD GAS TENSIONS BREATHING OXYGEN (TABLE I; FIG. 1) The addition of 2 litres oxygen per minute by nasal catheter to the inspired air in patients 6 and 9 produced marked differences in arterial Pco2 tensions and H+ during sleep. Both patients were restored to normoxia (mean sleep Po2 of 11 *0 and 11 *5 kPa respectively), but patient 9 had a mean rise in Pco2 of 0 1. kPa in the course of the night whereas patient 6 had a mean rise in PCO2 of 1 2 kPa with a rise in H+ from 46 to 51 nmol l-1. The maximum rises in Pco2 and H+ in patient 6 were 2-7 kPa and 10 Lmol 1-1. SLEEP (TABLE II) These patients proved to be very disturbed sleepers. As a group they slept a mean of 304-2 min out of a possible mean 'in bed' time of 429 9 min. Delay to sleep varied from 1-3 to 100 min, and much of the loss of sleep was due to prolonged wakeful periods during the night so that the mean percentage awake time was 309y%. Somewhat surprisingly for this age group (range 48-66 years), the amount of stage 4 orthodox sleep was greater than expected and reached values of over 11 % total sleep in four subjects. However, it was absent in three other subjects. Similarly, there was a great variation in REM (stage 5) sleep which was less than 10 % in the three patients with a mean Po2 of less than 5-3 kPa during sleep, and over 20% total sleep in four other patients. As a group these patients do not stay long in any stage of sleep and show frequent shifts between sleep stages which average 17H1 shifts per hour for the group, considerably more than we encountered in normal subjects in this age group in our laboratory. Also shown are the individual data for subjects 6 and 9 breathing air and breathing oxygen at 2 litres min-' by nasal cannulae. The only consistent change produced by oxygen therapy in the two patients studied was a marked reduction in time spent awake from 13-9 and 22 7% to 2-7 and 3 5 %. Patient 9 had marked increases in stages 4 and 5 REM sleep but stage 4 sleep decreased in patient 6 with only a small increase in stage 5 REM sleep.
Blood sampling, which involved the experimenter entering the room and working in proximity to the patient, did not substantially alter the patients' sleep and the number of occasions on which the subjects awoke before or during the blood sampling procedure averaged approximately two occasions per night out of an average number of 18 blood samples.
patients than the single observation of maximal Pco2 (Koo et al., 1975) .
When the mean Po2 and Pco2 values for our patients before and during sleep are plotted on an 02-CO2 diagram (Rahn and Fenn, 1955) with an assumed respiratory quotient of0 82 (Fig. 2) we find a rise in the alveolar-arterial oxygen partial pressure difference in the majority of patients. This confirms previous observations (Koo et al., 1975 ) that hypoxaemia in most of these patients is due to a combination of hypoventilation and ventilation-perfusion inequality.
DISCUSSION
The observed mean fall of arterial Po2 by 0-67 kPa (Table I) during sleep in our patients is consistent with similar observations in normal man (Robin et al., 1958; Sieker et al., 1960; Bristow et al., 1969; Koo et al., 1975) . The mean rise of Pco2 of 0-23 kPa during sleep in our patients is less than that observed by other workers who have shown that Pco2 rises on average by 0 37-0{86 kPa during sleep in normal subjects (Mangold et al., 1955; Birchfield et al., 1958; Robin et al., 1958; Billow, 1963; Bristow et al., 1969; Koo et al., 1975) . Our observations on changes in Pco2 during sleep are contrary to Robin's (1958) suggestion that patients with chronic respiratory failure, because they have a diminished ventilatory response to C02, will develop more marked hypercapnia in sleep than normal subjects. We have been unable to confirm Koo's finding (Koo et al., 1975) in a less severely disabled group of patients with chronic ventilatory failure that Pco2 rises more during sleep than in normal subjects. This is almost certainly related to the way in which the comparisons have been made in the two studies. We have calculated a mean Pco2 value for sleep in each of our patients from all the blood gas estimates (average no. 14) obtained during the study, whereas Koo et al. compared only the maximal rise in Pco2 in their patients during sleep with the maximal rise in controls. Since many of their patients had large rises in Pco2 during REM sleep this would account for the marked differences obtained in their study. In our study, 18 samples were obtained during REM sleep breathing air and none showed the presence of marked hypercapnia. However, the two peaks of Paco2 occurring when patient 6 was breathing oxygen (Fig. 1) both occurred in REM periods although this was not so for patient 9. Many of our patients had less than normal REM sleep (Table II) , and our presentation of the results for each individual as mean Pco2 during sleep more accurately represents the overnight blood gas status in our Our finding in these patients with chronic ventilatory failure that the mean fall in Po2 is similar to and the mean rise in Pco2 less than the changes found in normal subjects during sleep requires explanation. These patients were all extremely hypoxic, and during sleep with the development of hypoventilation and, in most cases, ventilation-perfusion imbalance the hypoxia worsened. If the hyperbolic relationship between ventilation and P02 (Lloyd, Jukes, and Cunningham, 1958; Weil et al., 1970) , which is found in awake man, applies during sleep then falls in Po2 of the order we have found would constitute a significant additional drive to ventilation in our \ ( 4 ) ALVEOLAR-, severely hypoxic patients whereas similar falls in P02 in normoxic man would have little or no effect on ventilation (Lloyd et al., 1958) . This added ventilatory drive would tend to limit the fall in Po2 and rise in Pco2 which would otherwise occur. The little evidence in man on the hypoxic drive to breathing during sleep suggests that, in contrast to the diminished ventilatory response to C02 found in sleep, the hypoxic drive is unaffected (Reed and Kellogg, 1960a and b) . Also there are animal experiments (Guazzi and Freis, 1969) showing that abolition of peripheral chemoreceptor activity by sino-aortic deafferentation exacerbates the hypoxaemia and hypercapnia of sleep, thus suggesting that chemoreceptor activity may be necessary to limit the hypoventilation of natural sleep. There are two additional findings in our study which support our hypothesis that hypoxaemia and hypercapnia are limited in these patients by the presence of an active hypoxic drive to breathing. The Pco2 tended to rise less or even fall (Table I) in these patients who were most hypoxic during sleep. It is reasonable to suggest that the most hypoxic patients, by virtue of the hyperbolic nature of the VE/PO2 relationship, had a greater hypoxic drive to breathing and were most likely to limit or reverse the expected rise in Pco2 during sleep. The second finding in support of our hypothesis is the effect of oxygen breathing on blood Pco2 tensions during sleep in the two patients with and without hypoxic drives to breathing (Fig. 1) . Patient 6, who was shown to have a hypoxic drive to breathing when awake, developed marked hypercapnia and respiratory acidosis when his Po2 was restored to normal levels during sleep. This would be consistent with the inhibition of his hypoxic drive to breathing and a resultant hypoventilation. In contrast, patient 9, who had no demonstrable hypoxic drive to breathing, developed no more C02 retention or acidosis during sleep, when restored to normoxia by oxygen breathing, than when he was hypoxic breathing air.
If our hypothesis that the unexpected change in blood gas tensions during sleep in these patients is due to hyperventilation brought about by an active hypoxic drive to breathing is correct, then this hyperventilation, in these patients with severe respiratory disability, may be the reason for the poor sleep patterns which we and others (Koo et al., 1975) have recorded in them (Table II) . Oxygen therapy would be the obvious solution to this sleep disturbance, and our limited experience with two patients would suggest that the quality of sleep does improve (Table II) although we have yet to demonstrate that this is due to relief of hyperventilation alone. The use of hypnotics in such patients does not seem to produce any greater rise in Pco2 than natural sleep (Gaddie et al., 1972) .
Long-term oxygen therapy is now used in the treatment of patients with cor pulmonale where it has been shown to diminish the polycythaemia, pulmonary hypertension, and number of episodes of cardiac failure in patients with this condition (Stark, Finnegan, and Bishop, 1972; Anderson et al., 1973; Leggett et al., 1976) . Oxygen therapy is given for 15 hours per day at a flow rate of 2 1/min by nasal catheters (Leggett et al., 1976) , all patients receiving oxygen during sleep. If the range of change in PCO2 and pH during sleep in these patients with oxygen therapy is as great as that observed in our two patients, then it may be that hypercapnia and acidosis during oxygen therapy at night will be factors influencing outcome in these patients. We would suggest that future trials of long-term oxygen therapy should include in their assessment procedure some measurement either of the hypoxic drive to breathing or of the blood acid-base changes during sleep while breathing oxygen. In this way, it will be possible to assess whether large changes in Pco2 and H+ during sleep are deleterious and, if so, allow the selection of the most appropriate inspired oxygen concentration for these patients at night. 
